FDA Notices of Judgment Collection, 1908-1966

16092. Adulteration and misbranding of ampuls of Endoquin (quinine hydrochloride), Endoferarsan with glycerophosphates (iron arsenic and glycerophosphates), Endoferarsan (iron and arsenic), and emetine hydrochloride. U. S. v. Intravenous Products Co. of America (Inc.). Plea of guilty. Fine, $200.